21-CHLORO-9-FLUORO-11-HYDROXY-16-METHYL-17-(1-OXOPROPOXY)-PREGNANE-3,20-DIONE, (5.BETA.,11.BETA.,16.BETA.)-
UNII BIQ5QQF56U
Substance Identification & Data
This profile provides standardized clinical and technical data for 21-chloro-9-fluoro-11-hydroxy-16-methyl-17-(1-oxopropoxy)-pregnane-3,20-dione, (5.beta.,11.beta.,16.beta.)-, uniquely identified by the FDA Unique Ingredient Identifier (UNII) BIQ5QQF56U.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 80042-35-9 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C25H36ClFO5 AJWNGOKNEBVXJK-LNLHLLADSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 21-chloro-9-fluoro-11-hydroxy-16-methyl-17-(1-oxopropoxy)-pregnane-3,20-dione, (5.beta.,11.beta.,16.beta.)-. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.